These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16823962)

  • 41. A precisely regulated gene expression cassette potently modulates metastasis and survival in multiple solid cancers.
    Yu K; Ganesan K; Tan LK; Laban M; Wu J; Zhao XD; Li H; Leung CH; Zhu Y; Wei CL; Hooi SC; Miller L; Tan P
    PLoS Genet; 2008 Jul; 4(7):e1000129. PubMed ID: 18636107
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metastasis suppressors: functional pathways.
    Khan I; Steeg PS
    Lab Invest; 2018 Feb; 98(2):198-210. PubMed ID: 28967874
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression.
    Lifsted T; Le Voyer T; Williams M; Muller W; Klein-Szanto A; Buetow KH; Hunter KW
    Int J Cancer; 1998 Aug; 77(4):640-4. PubMed ID: 9679770
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metastasis suppressor genes: signal transduction, cross-talk and the potential for modulating the behavior of metastatic cells.
    Berger JC; Vander Griend D; Stadler WM; Rinker-Schaeffer C
    Anticancer Drugs; 2004 Jul; 15(6):559-68. PubMed ID: 15205597
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic determinants of cancer metastasis.
    Nguyen DX; Massagué J
    Nat Rev Genet; 2007 May; 8(5):341-52. PubMed ID: 17440531
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A database study that identifies genes whose expression correlates, negatively or positively, with 5-year survival of cancer patients.
    Stein WD; Litman T; Fojo T; Bates SE
    Biochim Biophys Acta; 2007 Jun; 1770(6):857-71. PubMed ID: 17398010
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systems biology approach to identification of biomarkers for metastatic progression in cancer.
    Ptitsyn AA; Weil MM; Thamm DH
    BMC Bioinformatics; 2008 Aug; 9 Suppl 9(Suppl 9):S8. PubMed ID: 18793472
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor progression effects on drug vector access to tumor-associated capillary bed.
    Kiseliovas V; Milosevic M; Kojic M; Mazutis L; Kai M; Liu YT; Yokoi K; Ferrari M; Ziemys A
    J Control Release; 2017 Sep; 261():216-222. PubMed ID: 28576640
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug development against metastasis-related genes and their pathways: a rationale for cancer therapy.
    Iiizumi M; Liu W; Pai SK; Furuta E; Watabe K
    Biochim Biophys Acta; 2008 Dec; 1786(2):87-104. PubMed ID: 18692117
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Allelic diversity in the host genetic background may be an important determinant in tumor metastatic dissemination.
    Hunter KW
    Cancer Lett; 2003 Oct; 200(2):97-105. PubMed ID: 14568162
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genomics screens for metastasis genes.
    Yan J; Huang Q
    Cancer Metastasis Rev; 2012 Dec; 31(3-4):419-28. PubMed ID: 22684367
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular events in metastatic progression.
    Shekhar PV; Aslakson CJ; Miller FR
    Semin Cancer Biol; 1993 Jun; 4(3):193-204. PubMed ID: 8318695
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Understanding cancer metastasis: an urgent need for using differential gene expression analysis.
    Bashyam MD
    Cancer; 2002 Mar; 94(6):1821-9. PubMed ID: 11920546
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A systems biology approach to discovering pathway signaling dysregulation in metastasis.
    Clarke R; Kraikivski P; Jones BC; Sevigny CM; Sengupta S; Wang Y
    Cancer Metastasis Rev; 2020 Sep; 39(3):903-918. PubMed ID: 32776157
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Meeting report: tumor biology--how signaling processes translate to therapy.
    Friedrich K; Janssen O; Hass R
    Sci STKE; 2007 Apr; 2007(381):pe13. PubMed ID: 17426344
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Manipulation of prostate cancer metastasis by locus-specific modification of the CRMP4 promoter region using chimeric TALE DNA methyltransferase and demethylase.
    Li K; Pang J; Cheng H; Liu WP; Di JM; Xiao HJ; Luo Y; Zhang H; Huang WT; Chen MK; Li LY; Shao CK; Feng YH; Gao X
    Oncotarget; 2015 Apr; 6(12):10030-44. PubMed ID: 25888628
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Global secretome characterization of A549 human alveolar epithelial carcinoma cells during Mycoplasma pneumoniae infection.
    Li S; Li X; Wang Y; Yang J; Chen Z; Shan S
    BMC Microbiol; 2014 Feb; 14():27. PubMed ID: 24507763
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A systems biology approach to defining metastatic biomarkers and signaling pathways.
    Goldberger NE; Hunter KW
    Wiley Interdiscip Rev Syst Biol Med; 2009; 1(1):89-96. PubMed ID: 20835983
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Unlocking the power of cross-species genomic analyses: identification of evolutionarily conserved breast cancer networks and validation of preclinical models.
    Bennett CN; Green JE
    Breast Cancer Res; 2008; 10(5):213. PubMed ID: 18828875
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Specific tyrosine kinase inhibitors regulate human osteosarcoma cells in vitro.
    Messerschmitt PJ; Rettew AN; Brookover RE; Garcia RM; Getty PJ; Greenfield EM
    Clin Orthop Relat Res; 2008 Sep; 466(9):2168-75. PubMed ID: 18607665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.